Literature DB >> 24958444

Therapeutic strategies of urinary disorders in MS. Practice and algorithms.

P Denys1, V Phe2, A Even3, E Chartier-Kastler2.   

Abstract

OBJECTIVE: Review the literature on therapeutic strategies and guidelines for the treatment of neurogenic bladder in multiple sclerosis. MATERIAL AND
METHOD: A search on available articles on consensus, recommendations guidelines and algorithm of treatment of urinary tract dysfunction in multiple sclerosis.
RESULTS: Five national consensus guidelines were recently published and proposed guidelines for the first and second line treatments.
CONCLUSION: Multiple sclerosis patients suffering from lower urinary tract disorders must benefit from an early diagnosis and simple first line evaluation and treatment. More complex and invasive evaluation in the neuro-urology unit is appropriate for patients who failed to first line treatment or in case of complications.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Antimuscarinic; Antimuscarinique; Incontinence; Multiple sclerosis; Neurogenic bladder; Sclérose en plaques; Vessie neurogène

Mesh:

Year:  2014        PMID: 24958444     DOI: 10.1016/j.rehab.2014.05.003

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  4 in total

1.  Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Authors:  A Ghezzi; E Mutta; F Bianchi; S Bonavita; F Buttari; A Caramma; R Cavarretta; D Centonze; G C Coghe; G Coniglio; U Del Carro; M T Ferrò; M G Marrosu; F Patti; M Rovaris; M Sparaco; I Simone; C Tortorella; R Bergamaschi
Journal:  Neurol Sci       Date:  2015-11-27       Impact factor: 3.307

2.  Tablet-based screening improves continence management in multiple sclerosis.

Authors:  Heidi N Beadnall; Kushi E Kuppanda; Annmaree O'Connell; Todd A Hardy; Stephen W Reddel; Michael H Barnett
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

Review 3.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

4.  Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data.

Authors:  Elena Andretta; Enrico Finazzi Agrò; Massimiliano Calabrese; Luca Orecchia; Antonietta Furlan; Cristina Zuliani
Journal:  Ther Adv Urol       Date:  2022-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.